AN ASSESSMENT OF THE CLINICAL RELEVANCE OF SERUM IL-21 LEVEL AFTER DISCONTINUATION OF NUCLEOS(T)IDE

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户:lokimi
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:To evaluate the chronic hepatitis b(CHB) patients by nucleoside(acid),drugs(NAs) after discontinuation of treatment serum levels of IL-21 and its relationship with HBsAg and HBV DNA,working on the role of IL-21 in maintaining sustained response after coming off the drugs.Methods:The double antibody sandwich ELISA method for detection of 20 patients with CHB stopping the dynamic change of serum IL-21 in patients during the follow-up process,analyzing the correlation between HBsAg and HBV DNA and serum IL-21.
其他文献
Background:Therapeutic strategy to activate host innate immunity,like toll-like receptor 7(TLR7) agonist,had a great potential for the treatment of chronic hepatitis B(CHB).Here we investigated the mo
会议
Background:Objectives:Fuzheng Huayu(FZHY) capsule,a Chinese medicine,is widely administrated to treat hepatic fibrosis and cirrhosis in the clinic in China for twenty years.This abstract is about to s
会议
Background:The zinc finger protein A20(also known as TNFAIP3) is a cytoplasmic protein and mediates the regulation of ubiquitin-dependent signaling in inflammation and immunity.Complex immune networks
会议
Background:Incidence of NAFLD(nonalcoholic fatty liver disease) is increasing as a cause of chronic liver disease.Also,obesity and diabetes are risk factors for the development of hepatocellular carci
会议
Background:It is of great importance to early and accurately predict the prognosis of patients with acute-onchronic hepatitis B liver failure(ACHBLF) for optimum management.The promoter methylation of
会议
Background:Hepatitis B virus core-related antigens(HBcrAg) are comprised of hepatitis B core antigen(HBcAg),hepatitis E antigen(HBeAg) and a 22 kDa precore protein(P22cr).HBcrAg concentrations were we
会议
Background:To compare the efficacy and safety of 52-week sequential therapy with telbivudine and other nucleoside analogs(NAs) in HBeAg-positive Chronic Hepatitis B Patients(CHB) patients with subopti
会议
Background:To characterize roles of serum hepatitis B virus markers(HBVM) quantitations in the prediction of natural phases of HBV infection.Methods:149 patients of chronic hepatitis B(CHB) undergone
会议
Background:Hepatitis B surface antigen clearance induced by interferon-α is associated with favorable clinical outcome.In this study,we investigated HBsAg kinetics during pegIFNα treatment and durabil
会议
Background:To discuss the dynamic changes of serum hepatitis B surface antigen(HBsAg) levels,and the serum HBsAg levels apportioned by the same hepatic parenchyma cell volume(HPCV),namely hepatic cell
会议